Background: The histone deacetylase (HDAC) inhibitor, which has potential effects on epigenetic modifications, had been reported to attenuate renal fibrosis. CD4 + forkhead box P3 (FOXP3) + T regulatory (Treg) cells may be converted to inflammation-associated T helper 17 cells (Th17) with tissue fibrosis properties. The association between FOXP3
The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3 Conclusions: TSA treatment decreased JG hyperplasia, the percentage of FOXP3 + IL-17 + cells and the degree of fibrosis, suggesting that therapeutic benefits may result from epigenetic modifications.
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Background
Renal fibrosis arises in most progressive renal diseases, regardless of the disease underlying end-stage kidney disease [1, 2] . The unilateral ureteral obstruction (UUO) model presents renal fibrosis unrelated to hypertension or systemic immune disease [3, 4] . Kidney obstruction after UUO results in tubular injury and cell death by apoptosis or necrosis [5] [6] [7] . One prior study has revealed the pivotal role of CD4 + T cells in renal fibrosis following ureteric obstruction [8] . The subtype of CD4 + T cell involved remains unclear. The context of T cell activation determines whether fibrocyte development is supported or blocked. Murine fibrocytes develop from a subpopulation of CD11b + CD115 + Gr1 + monocytes under the control of CD4 + T cells [9] . In one mouse bronchiolitis obliterans model, the interleukin (IL)-17 level has been shown to increase locally in the absence of a change in the number of peripheral blood T helper (Th) 17 cells, whereas the number of peripheral T regulatory cells (Tregs) was shown to decrease [10] . Th17 cells, which are regulated by IL-6 stimulation, may therefore play a role in post-transplantation allograft rejection. One UUO study has identified intra-renal dendritic cells as an early source of proinflammatory mediators after acute urinary obstruction and has found that they play specific roles in the recruitment and activation of effector-memory T cells, including Th17 cells [11] [14] . These studies have indicated that a regulatory arm of the immune response may develop along similar lines as the effector arm. These findings imply that Treg development exhibits a degree of plasticity to meet local conditions. Cells expressing IL-17 and retinoic acid receptor-related orphan receptor (RORγt) are present in lung tissue and digestive mucosal compartments [15] . Koenen 
Methods

Ethic statement
This animal study was performed in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Laboratory Animal Center. The experimental protocol was approved by the Animal Care Committee of the Taichung Veterans General Hospital (Permit Numbers: La-101,944 and La-1,021,085). The mice had free access to tap water and standard mouse feed.
UUO mouse model
These studies were conducted on male C57BL/6 mice (approximately 20 g in weight) obtained from the National Laboratory Animal Center (Taipei, Taiwan). The UUO mice underwent surgery as described previously [3, 16, 17] . The mice were anesthetized with Rampun (xylazine hydrochloride) and Zoletil (a mixture of tiletamine hypochloride and zolazepam hypochloride), and the left kidney and ureter were exposed via flank incision. To prevent a retrograde urinary tract infection, the left ureter was ligated with 4-0 silk at two points at the ureterovesical junction and was cut between the ligatures. Finally, the wound was closed in layers. The mice were maintained in a temperature-controlled room, and their vital signs were monitored regularly after surgery. Following UUO, TSA (0.5 mg/kg) was first administered intraperitoneally (I.P.) and then by daily injection for 7, 14 or 21 days. The mice were randomized into groups of six as follows: 
Histopathological and immunohistochemical (IHC) analyses
Formalin fixation and paraffin embedding of the bilateral renal specimens were performed according to previously described procedures [16] . The primary antibodies used were anti-mouse mAbs (anti-CD4 Ab, Leica, Leica Biosystems, Newcastle, UK and anti-IL-17 Ab, Abcam, Cambridge, UK), and the secondary antibody used was a rabbit monoclonal anti-FOXP3 antibody (Abcam, Cambridge, UK). Renal fibrosis was assessed with Masson trichrome staining using a commercial kit (Abcam; ab150686).
The semiquantitative evaluations and grading of the IHC staining were performed by two independent investigators. The number of CD4 + FOXP3 + , CD4 + IL-17 + , or FOXP3 + IL-17 + cells was determined according to the number of positive cells per high-powered field (HPF) at 400X magnification from 10 randomly chosen fields within the same section of kidney tissue from an individual biopsy specimen [14] . The interstitial volume, α-smooth muscle actin (α-SMA) score were calculated by the point counting method in accordance with previous reports [16, 18] .
Splenic cell separation and culture
Mouse spleens and kidneys were cut into pieces, milled with a tissue grinder, and filtered using a 70-μm strainer (BD FALCON, USA). Splenocytes were isolated by Ficoll-Paque gradient centrifugation (GE Healthcare, Sweden). Mononuclear spleen cells (1 × 10 6 cells/well) were cultured with IL-2 (10 pg/mL) (BD PHARMIN-GEN) in Roswell Park Memorial Institute (RPMI)-1640 medium containing 10% fetal bovine serum for 6 days and analyzed by flow cytometry.
Splenic cells were incubated with magnetic beads coated with an antibody against CD4 using a commercial magnetic-activated cell sorting (MACS) kit (Mitenyi Biotec). FOXP3 + IL-17 + cells were subsequently sorted by fluorescence-activated cell sorting (FACS) (purity >95%) and checked by flow cytometry (FC500, Beckman Coulter, Fullerton, CA).
Flow cytometry
Cells were stimulated with IL-2 for 6 days and then treated with phorbol myristate acetate (PMA) (50 ng/ mL) and ionomycin (1 μg/mL) for 4 h before analysis. Splenic or renal mononuclear cells were fixed using a Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA, USA) and were then stained with fluorescein-conjugated mAbs with isotopes against CD4, TGF-β1, Annexin V, FOXP3 and IL-17 (BD Biosciences + cells was performed with a commercial MACS kit according to the manufacturer's instructions [19] .
Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Real-time quantitative RT-PCR analyses of IL-17, TGF-β1, FOXP3 and RORγt mRNA were performed using a SYBR Green PCR Kit (Applied Biosystems, California). The specific primers used were as follows: IL-17: 5'-ATCAGGACGCGCAAACATG-3' (sense) and 5'-TGA TCGCTGCTGCCTTCAC-3' (antisense); TGF-β1: 5'-TG CGCTTGCAGAGATTAAAA-3' (sense) and 5'-CGTC AAAAGACAGCCACTCA-3' (antisense); FOXP3: 5'-GGT TAGGAGACATCCATCAGG-3' (sense) and 5'-CAGG GAGGAGTTCAGTAGAGG -3' (antisense); RORγt: 5'-TCTGCAAGACTCATCGACAAGG-3' (sense) and 5'-TC AGGGGATTCAACATCAGTGC -3' (antisense); and glyceraldehyde 3-phosphate dehydrogenase (GADPH): 5'-ACTCCACTCACGGCAAATTC-3' (sense) and 5'-TCTC CATGGTGGTGAAGACA-3' (antisense).
The mRNA expression was calculated as the fold change using the 2 △Ct formula as follows: △C T = △C T (control)-△C T (target), where C T indicates the cycle threshold [19] .
Knockdown by siRNA for IL-17
One pair of small-interfering RNAs (siRNA) targeting IL-17 were synthesized by Ambion (Life Technologies Corporation, Taiwan). FOXP3
+ IL-17 + T cells transfected with IL-17 siRNA (20 μM) in six-well plates using Lipofectamine RNAiMAX reagent, according to the manufacturer's protocol (Life Technologies). The Ambion's silencer negative control siRNA was used to knockdown expression of IL-17 and IL-17, TGF-β1 protein levels were confirmed by immunoblotting, the targeted fragment of siRNA against IL-17 was: sense (5 '→ 3') AAGAGAUCCUGGUCCUGAAtt, anti-sense: UUCAGGACCAGGAUCUCUUgc. Quantitative data were obtained by computing densitometer and Image Quant software [19] .
Western blot analysis
Total protein was extracted from kidney tissues or isolated cells. Cell proteins were separated on a precast polyacrylamide gel (10%), transferred to a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ) and probed with primary antibodies at 4°C overnight, followed by incubation with horseradish peroxidase (HRP)-labeled secondary antibodies for 1 h at room temperature. Protein bands were detected using enhanced chemiluminescence reagents (Amersham Biosciences, Piscataway, NJ) [19] .
Statistical analysis
The data are presented as the mean ± SD. Intergroup differences were analyzed by independent t test or analysis of variance (ANOVA) followed by Duncan's test. A p value of <0.05 was considered significant.
Results
UUO induces juxtaglomerular (JG) hyperplasia, angiotensin II type 1 receptor (AT1R) expression and lymphocyte infiltration
The top row of Fig. 1a shows hematoxylin-eosin (HE) and α-SMA staining on days 7, 14, and 21 after UUO in the kidney tissues of the UUO mice. Tubular dilatation, tubular atrophy and a widened interstitial space with increased interstitial lymphocyte infiltration were found in the obstructed kidneys. The tubulointerstitial damage progressed after UUO. We examined interstitial myofibroblasts, which are characterized by α-SMA expression (Fig. 1a) . The expression of α-SMA in the cortical interstitium of the UUO mice was the highest after 21 days of UUO. Renin-angiotensin system (RAS) activation, with T-cell activation and infiltration, is thought to play a key role in the pathogenesis of renal fibrosis [20] [21] [22] , but the detailed phenotypes of T-cell subsets are poorly understood. We analyzed serial changes in JG cells and AT1R expression in the kidney tissues of the UUO mice. We found progressively increasing JG cell hyperplasia in the JG apparatus, accompanied by enhanced AT1R expression in epithelial cells and lymphocytes after UUO (lines 2-3 of Fig. 1a) . Progressively increasing lymphocyte infiltration was noted in the interstitium of the renal tissues after UUO. The most prominent AT1R expression in renal lymphocytes was observed at 14 days after UUO. (Fig. 1b) . The number of CD4 + FOXP3 + T cells was 3.5 ± 0.8 cells/HPF in the 7-days group, and it increased to 7. progressively decreased in number by the 21st day and were associated with renal fibrosis in the UUO mice.
The TGF-β1 and IL-17 mRNA levels increased with duration of UUO
We next examined the expression of TGF-β1 and IL-17 mRNA in obstructed kidneys induced by UUO. TGF-β1 mRNA expression increased significantly in the UUO kidneys compared with sham-operated kidneys. After UUO, the relative level of IL-17 mRNA rose significantly in the UUO mice at 21 versus 14 and 7 days. Specifically, the relative level of TGF-β1 mRNA was the highest in the 14-days group, and it was decreased in the 21-days group. We found that the TGF-β1 mRNA and IL-17 mRNA levels were positively correlated (r 2 =0.792).
The Th17 phenotype is generated from Treg cells, and TSA treatment reduces renal fibrosis HE staining of kidney tissues from the UUO mice showed decreased fibrosis after the I.P. TSA treatment (Fig. 2a) Masson trichrome staining revealed increased collagen deposition in the renal tissues after UUO for 7, 14 and 21 days (Fig. 3) . The collagen deposition decreased after TSA treatment. IHC for type 1 collagen and fibronectin were also showed positive stain after UUO for 7, 14 and 21 days (Fig. 3) .
Flow cytometry detected CD4 + FOXP3 + IL-17 + T cells after 14 (Fig. 4a , bottom left) and 21 days (Fig. 4b, bot Fig. 4a , bottom right) and after 21 days (without TSA vs. TSA: 12.4 ± 2.3 vs. 4.4 ± 0.6%, p < 0.05, n = 6, Fig. 4b, bottom right) . TSA enhanced the appearance of apoptotic IL-17 + Annexin + cells (day 14: without TSA vs. TSA: 0.5 ± 0.1 vs. 8.4 ± 1.2%, p < 0.05, n = 6; day 21: without TSA vs. TSA: 0.9 ± 0.3 vs. 17.6 ± 2.1%, p < 0.01, n = 6; Fig. 4c ).
Up-regulation of FOXP3 and down-regulation of RORγt mRNA expression after UUO and was modifiable by TSA treatment Figure 5 shows increased FOXP3 and RORγt mRNA expression in kidney tissue after UUO. After the TSA treatment, the FOXP3 mRNA expression level increased (Fig. 5a ). RORγt mRNA expression was continuously suppressed by TSA (Fig. 5b) . STAT3 activation involved in renal fibrosis had been reported [23] . Our result of western blot showed TSA inhibited STAT3 phosphorylation after UUO for 14 days (p < 0.05, Fig. 6 ). Western blot was also arranged to analyze the protein levels of fibronectin and type 1 collagen, which are markers for renal fibrosis. It also showed TSA inhibited the increase of fibronectin and type 1 collagen induced by UUO (p < 0.001, Fig. 7 ). Fig. 8a ), but they decreased in number after 21 days (UUO vs. controls: 7.8 ± 0.8 vs. 0.9 ± 0.3%, p < 0.05, n = 6, Fig. 8b ). These findings corresponded with the double immunostaining findings in the renal tissues. siRNA. We found that IL-17 expression significantly decreased accompany with decreasing TGF-β1 (Fig. 9) . These results demonstrated that IL-17 regulates TGF-β1 expression in FOXP3 + IL-17 + T cells. Splenic cells were incubated with magnetic beads coated with an antibody against CD4. FOXP3 + IL-17 + cells were isolated and sorted (purity >95%) and were then checked by flow cytometry. Western blotting for TGFβ1, FOXP3, and IL-17 expression in splenic CD4 + FOXP3 + IL-17 + T cells on days 0, 7, and 14 showed that the increased TGFβ1 expression occurred after 7 and 14 days (Fig. 10 
Discussion
We observed lymphocyte infiltration in obstructed kidneys after UUO. + T cells after UUO, but this requires further examination in the future to obtain stronger evidence. We measured TGF-β1 mRNA expression and found that it was positively correlated with IL-17 mRNA expression in UUO renal tissues, suggesting a link between Th17 cells and renal fibrosis. We perfused renal arteries with 0.9% normal saline and washed out circulating blood before harvesting to prevent contamination of the renal tissues with systemic mononuclear cells. With minimal contamination, the accuracy of flow cytometry for the kidney cells was high, and the CD4 + FOXP3 + , CD4 + FOXP3 + IL-17 + and CD4 + IL-17 + T cells were unlikely to have resulted from systemic blood contamination.
Prominent roles of Treg and Th17 cells in chronic diseases have been reported in previous studies. Nakagiri et al. have shown that IL-17 production increases locally in the absence of a change in the number of peripheral blood Th17 cells and that the number of peripheral Tregs decreases after allografts in a mouse bronchiolitis obliterans model. Adoptive Treg cell transfer has been Fig. 3 Masson trichome staining revealed increased collagen deposition in the renal tissues after UUO for 7, 14 and 21 days and decreased after TSA treatment (400X). IHC for type 1 collagen and fibronectin were also revealed positive stains after UUO for 7, 14 and 21 days (400X) shown to be beneficial in animal models of diabetes, arthritis, transplantation and renal disease [24] [25] [26] [27] [28] . Heda Kvakan et al. have demonstrated that Treg cell transfer reduces cardiac hypertrophy and fibrosis [12] . Prior studies have shown that human Tregs can be converted into Th17 cells [15, 29, 30] . IL-17 has been identified as being fundamental to TGF-β1-derived fibrosis [31] . + cells, as well as the severity of renal fibrosis, were decreased with TSA treatment. Masson trichrome staining also revealed collagen deposition in renal tissues decreased after TSA treatment. Western blot showed the protein levels of type 1 collagen and fibronectin were decreased after TSA treatment which represented the anti-fibrotic effects of TSA treatment. These results are compatible with the pervious study [23] . The antifibrotic effects of TSA may be related to suppression of the conversion of Tregs into Th17 cells. Expression of FOXP3 and RORγt mRNA was increased after UUO in this study. After TSA treatment, FOXP3 mRNA expression was elevated. RORγt mRNA expression rose after UUO but fell after TSA treatment. + TGF-β1 + T cells, the percentage of which was increased after UUO for 7 or 14 days. After TSA treatment, this percentage decreased into Th17 cells in psoriasis patients in a previous study [14] . In addition, an earlier study has revealed that TSA inhibition induces anti-fibrotic activity by inactivating renal interstitial fibroblasts and inhibiting renal tubular cell death. STAT3 may mediate the actions of HDACs [23] . Mao-yin Pang has suggested that TSA has a pharmacological anti-fibrotic effect that occurs via the suppression of renal interstitial fibroblasts and the inhibition of renal tubular cell death [23] . Yoshikawa et al. have examined the effect of TSA on the epithelial-mesenchymal transition (EMT) in cultured tubular epithelial cells and have found that TSA prevents the TGF-β1-induced EMT [32] . They have revealed that TSA induces the expression of inhibitor of DNA binding 2 (ID2) and bone morphogenetic protein-7 (BMP-7), which are both inhibitors of TGF-β1 signaling. Imai N. et al. have shown that TSA treatment attenuates the progression of proteinuria and glomerulosclerosis in a mouse model of nephrotoxic serum nephritis (NTN) by promoting BMP-7 expression [33] . Hence, HDACs may contribute to renal fibrosis through multiple mechanisms.
To date, data on the correlation between the plasticity of Treg development and renal fibrosis are limited. We have demonstrated a CD4 + FOXP3 + Treg effector differentiation program that yields Th17 + cells that induce TGF-β1 mRNA expression and renal fibrosis in UUO kidneys. Our data suggest that epigenetic modifications underlie this phenomenon. Flexibility in Treg differentiation programming may have evolved to anticipate local microenvironmental regulation. Notably, the presence of TGF-β1-secreting FOXP3 + IL-17 + T cells in the proinflammatory environment suggests a role for these cells in the conversion of Tregs into IL-17-producing cells, as well as TGF-β1-producing cells, inadvertently contributing to the perpetuation of both inflammatory conditions and remodeling. These observations provide insights into a previously unreported mechanism of inflammation and remodeling. However, further research is necessary to evaluate the interaction between IL-7 and TGF-β1 and its signaling pathways.
Conclusions
In summary, UUO induces lymphocyte invasion. Tregs differentiate into Th17 cells in renal tissue after UUO. The numbers of both TGF-β1-producing FOXP3 
